Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22323663 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: terameprocol;   Other: pharmacological study

Indicates status has not been verified in more than two years